Investor Announcements - 2014


2

The open offer to qualifying participants has been over-subscribed.

EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers.

EKF Diagnostics announces its audited final results for the year ended 31 December 2013, a year of strong organic growth and improved earnings.

2